PVLA
Palvella Therapeutics (PVLA)
$20
About Palvella Therapeutics (PVLA)
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.
Details
Daily high
$85.04
Daily low
$78.93
Price at open
$78.93
52 Week High
$114.69
52 Week Low
$14.68
Market cap
973.0M
Dividend yield
0.00%
Volume
396,365
Avg. volume
244,451
P/E ratio
-6.52
Palvella Therapeutics News
Details
Daily high
$85.04
Daily low
$78.93
Price at open
$78.93
52 Week High
$114.69
52 Week Low
$14.68
Market cap
973.0M
Dividend yield
0.00%
Volume
396,365
Avg. volume
244,451
P/E ratio
-6.52